Oorsprong van het eerstegraads netwerk van Philippe Guedat
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Inflectis Bioscience SAS
Inflectis Bioscience SAS BiotechnologyHealth Technology Inflectis Bioscience SAS develops therapeutics for the treatment of protein misfolding diseases. The firm engages in the development of new chemical series for the treatment of non-orphan diseases whose etiology also lies in the accumulation of misfolded proteins. The company was founded in September 2013 by Philippe Guedat and Pierre Miniou and is headquartered in Nantes, France.
5
| Holding Company | Biotechnology | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Philippe Guedat via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
NAVIDEA BIOPHARMACEUTICALS, INC. | Medical Specialties | Chief Executive Officer | |
ALSERES PHARMACEUTICALS, INC. | Medical Specialties | President | |
PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Actimis Pharmaceuticals, Inc.
Actimis Pharmaceuticals, Inc. BiotechnologyHealth Technology Actimis Pharmaceuticals, Inc. provides pharmaceutical research and development services. it focuses on the development of small therapeutics for respiratory and inflammatory disorders. The company was founded by Kevin B. Bacon in November 2004 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
Boston Biomedical, Inc.
Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sumitomo Chemical Co., Ltd., Boston Biomedical, Inc. is a developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. The company is based in Norwood, MA. The company's most advanced research programs are focused on investigational agents that inhibit multiple oncogenic pathways, including cancer stemness pathways, and modifying immune responses. The company was founded by Chiang J. Li. Boston Biomedical was acquired by Sumitomo Pharma Co., Ltd. on April 25, 2012 for $2,630 million. | Miscellaneous Commercial Services | Director/Board Member | |
Agilis Biotherapeutics LLC
Agilis Biotherapeutics LLC BiotechnologyHealth Technology Agilis Biotherapeutics LLC operates as a biotechnology company. It focuses on designing and engineering first-in-class DNA-based therapeutics to improve and save the lives of patients affected by life-threatening or fatal rare diseases for which there are no or limited treatment options. The company was founded in 2013 and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer | |
University of Pennsylvania | College/University | Doctorate Degree | |
Health Builders International, Inc.
Health Builders International, Inc. Financial ConglomeratesFinance Health Builders International, Inc. is an American development stage company. | Financial Conglomerates | Director/Board Member | |
CORDLIFE GROUP LIMITED | Medical/Nursing Services | President | |
PHARMING GROUP N.V. | Pharmaceuticals: Major | Director/Board Member | |
Cytomatrix
Cytomatrix Miscellaneous Commercial ServicesCommercial Services Part of Cordlife Group Ltd., Cytomatrix is a company that researches, develops, and commercializes novel cell growth systems for hematopoietic (blood) stem cells. The company is based in Woburn, MA. The company was founded by Mark Jerome Pykett. Cytomatrix was acquired by Cordlife Group Ltd. on April 30, 2003 for $11 million. | Miscellaneous Commercial Services | Chief Executive Officer | |
Amherst College | College/University | Undergraduate Degree | |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Masters Business Admin | |
The Pennsylvania State University | College/University | Masters Business Admin | |
Mitsui & Co. Global Investment, Inc.
Mitsui & Co. Global Investment, Inc. Investment ManagersFinance Mitsui & Co. Global Investment, Inc. (Mitsui & Co. Global Investment) is a venture capital subsidiary of Mitsui Ventures founded in 1999. The firm is headquartered in Menlo Park, California. | Investment Managers | President | |
Mitsui & Co. Global Investment Ltd.
Mitsui & Co. Global Investment Ltd. Investment ManagersFinance Mitsui & Co. Global Investment Ltd is a private Equity/venture Capital firm, a subsidiary of Mitsui & Co., Ltd. founded in 1996. The firm is headquartered in Tokyo. | Investment Managers | Private Equity Investor | |
Kyoto University | College/University | Undergraduate Degree | |
GO Capital SAS
GO Capital SAS Investment ManagersFinance GO Capital SAS (GO Capital) is an independent French private equity firm founded 2003 and is headquartered in Saint-Jacques-de-la-Lande. Formerly known as Grand Ouest Gestion SAS, the firm's investors include regional and cooperative banks, Natixis and CDC PME.GO Capital is located in Rennes and focuses primarily on the northwest quarter of France, also known as Grand Ouest, which comprises the Brittany, Poitou-Charentes, Pays de la Loire and Basse Normandie regions. The firm manages the Ouest Ventures fund. | Investment Managers | Chief Executive Officer | |
University of Nice Sophia Antipolis | College/University | Undergraduate Degree | |
Novartis Nutrition SAS
Novartis Nutrition SAS Pharmaceuticals: MajorHealth Technology Part of Fresenius SE & Co. KGaA, Novartis Nutrition SAS is a French company that manufactures nutrition and medical devices for enteral feeding. The company is based in Revel, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Tc Land Expression SA
Tc Land Expression SA Miscellaneous Commercial ServicesCommercial Services Tc Land Expression SA operates as a molecular diagnostic company. It focuses on the development and commercialisation of tests aimed at monitoring patients with immunological conditions. The firm specializes in the area of organ transplantation and immune mediated disorders. Its development programs encompass RA-INF-Dx, IMD Dx2, IMD Dx3, and L-TolX. The company was founded by Marina Guillet and Alain Huriez in November 2002 and is headquartered in Huningue, France. | Miscellaneous Commercial Services | Director of Finance/CFO | |
AUGURE CORPORATE France
AUGURE CORPORATE France Packaged SoftwareTechnology Services Augure SA develops and provides public relations and reputation management software. It offers cloud-based solutions for influencer marketing, communications content distribution, audience interaction, social media monitoring, brand impact metrics, and real-time market data analysis. The company was founded by Michael Jais, Fabien Barzic, and Gilles Andre in 2002 and is headquartered in Paris, France. | Packaged Software | Director/Board Member | |
CANBAS CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
Anaeropharma Science, Inc.
Anaeropharma Science, Inc. BiotechnologyHealth Technology Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan. | Biotechnology | Director/Board Member | |
Oramax LLC | Director/Board Member | ||
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Medical Specialties | Director/Board Member | |
Novartis Pharmaceuticals
Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The company is based in Basel, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Dana Capital Group, Inc. | Corporate Officer/Principal | ||
BIOAMBER INC. | Chemicals: Specialty | Director/Board Member | |
NapaJen Pharma, Inc.
NapaJen Pharma, Inc. Pharmaceuticals: MajorHealth Technology NapaJen Pharma, Inc. develops drug delivery technology solutions through cellular transport pathways. Its products include lead platform and drug delivery. The firm specializes in the development of novel drug delivery systems by utilizing natural transport pathways whose cells are used to move molecular cargo into themselves and across internal compartments. The company was founded by Dr. Kazuo Sakurai and Hironori Ando in December 2004 and is headquartered in Burlingame, CA. | Pharmaceuticals: Major | Director/Board Member | |
OMEICOS Therapeutics GmbH
OMEICOS Therapeutics GmbH BiotechnologyHealth Technology OMEICOS Therapeutics GmbH develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation. It operates as a biopharmaceutical company developing molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation. The company was founded by Wolf-Hagen Schunck, John R. Falck, Dominik Müller, Robert Fischer and Karen Uhlmann in 2013 and is headquartered in Berlin, Germany. | Biotechnology | Director/Board Member | |
University of Pennsylvania School of Veterinary Medicine | College/University | Doctorate Degree | |
Exubrion Therapeutics , Inc.
Exubrion Therapeutics , Inc. Medical SpecialtiesHealth Technology Exubrion Therapeutics, Inc. develops electron therapeutic veterinary devices. The company is based in Buford, GA. The company was founded by Dennis F. Steadman. The CEO is Peter Selover. | Medical Specialties | Director/Board Member | |
MyoPax GmbH
MyoPax GmbH BiotechnologyHealth Technology MyoPax GmbH is a biotech start-up located in Germany and Denmark that focuses on innovative regenerative therapies for muscle disorders. The German company was spun out of the Charité Universitätsmedizin and the Max Delbrück Center in the Helmholtz Association and joined the BioInnovation Institute in Copenhagen with pre-seed funding. MyoPax leverages its proprietary muscle stem cell technology and cutting-edge gene editing technologies to transform the treatment landscape and improve the quality of life for patients affected by muscle disorders. | Biotechnology | Chairman | |
Myrtelle, Inc. | Chief Executive Officer |
Statistieken
Internationaal
Verenigde Staten | 25 |
Frankrijk | 8 |
Japan | 5 |
Duitsland | 4 |
Australië | 2 |
Sectoraal
Health Technology | 19 |
Consumer Services | 9 |
Commercial Services | 5 |
Finance | 5 |
Producer Manufacturing | 2 |
Operationeel
Director/Board Member | 20 |
Corporate Officer/Principal | 8 |
President | 7 |
Chief Executive Officer | 5 |
Masters Business Admin | 3 |
Sterkste connecties
Insiders | |
---|---|
Mark Pykett | 19 |
Taro Inaba | 14 |
Philippe Jaffré | 9 |
Jerome Gueret | 3 |
Pierre Miniou | 2 |
- Beurs
- Insiders
- Philippe Guedat
- Bedrijfsconnecties